Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Antiinflammatory Effects of Budesonide in Human Fetal Lung.

Barrette AM, Roberts JK, Chapin C, Egan EA, Segal MR, Oses-Prieto JA, Chand S, Burlingame AL, Ballard PL.

Am J Respir Cell Mol Biol. 2016 Nov;55(5):623-632.

2.

Building the bridge from pediatric to adult diabetes care: making the connection.

Egan EA, Corrigan J, Shurpin K.

Diabetes Educ. 2015 Aug;41(4):432-43. doi: 10.1177/0145721715581666. Epub 2015 Apr 27.

PMID:
25916493
3.
4.

Community-level Effects of Individual and Peer Risk and Protective Factors on Adolescent Substance Use.

Egan EA, Van Horn ML, Monahan KC, Arthur MW, Hawkins JD.

J Community Psychol. 2012 May;39(4):478-498.

5.

In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus.

Mikkelsen SR, Reckling SK, Egan EA, Dean GA.

Virology. 2010 Aug 1;403(2):163-72. doi: 10.1016/j.virol.2010.04.016. Epub 2010 May 14.

6.

Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Howard KE, Reckling SK, Egan EA, Dean GA.

Retrovirology. 2010 Jan 19;7:2. doi: 10.1186/1742-4690-7-2.

7.

beta-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes.

Mani SK, Egan EA, Addy BK, Grimm M, Kasiganesan H, Thiyagarajan T, Renaud L, Brown JH, Kern CB, Menick DR.

J Mol Cell Cardiol. 2010 Feb;48(2):342-51. doi: 10.1016/j.yjmcc.2009.11.007. Epub 2009 Nov 27.

8.

Delimiting hospitalist liability.

Egan EA.

Virtual Mentor. 2008 Dec 1;10(12):810-2. doi: 10.1001/virtualmentor.2008.10.12.hlaw1-0812. No abstract available.

9.

Informed consent: when and why.

Egan EA.

Virtual Mentor. 2008 Aug 1;10(8):492-5. doi: 10.1001/virtualmentor.2008.10.8.ccas2-0808. No abstract available.

10.

Neuroimaging as evidence.

Egan EA.

Am J Bioeth. 2007 Sep;7(9):62-3. No abstract available.

PMID:
17849348
11.

Who should regulate the practice of medicine?

Egan EA.

J Opioid Manag. 2005 Mar-Apr;1(1):11-2. No abstract available.

PMID:
17315405
12.

The clinical response to brain death: a policy proposal.

Burck R, Anderson-Shaw L, Sheldon M, Egan EA.

JONAS Healthc Law Ethics Regul. 2006 Apr-Jun;8(2):53-9. Review.

PMID:
16755234
13.

School-based interventions for anxious children.

Bernstein GA, Layne AE, Egan EA, Tennison DM.

J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1118-27.

14.

Bioterrorism defense education: prioritizing public health education.

Egan EA.

Am J Bioeth. 2005 Fall;5(4):47-8. No abstract available.

PMID:
16109696
15.

Maternal phobic anxiety and child anxiety.

Bernstein GA, Layne AE, Egan EA, Nelson LP.

J Anxiety Disord. 2005;19(6):658-72.

PMID:
15927779
16.

Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.

Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA; Pediatric Acute Lung Injury and Sepsis Investigators.

JAMA. 2005 Jan 26;293(4):470-6. Erratum in: JAMA. 2005 Aug 24;294(8):900.

PMID:
15671432
17.

Testing the goodness-of-fit of a multifaceted preventive intervention for children at risk for conduct disorder.

Realmuto GM, August GJ, Egan EA.

Can J Psychiatry. 2004 Nov;49(11):743-52.

PMID:
15633852
18.

Comparing ethics education in medicine and law: combining the best of both worlds.

Egan EA, Parsi K, Ramirez C.

Ann Health Law. 2004 Winter;13(1):303-25, table of contents.

PMID:
15002186
19.

Preoperative screening: medical or legal guidelines?

Tonelli M, Egan EA.

Virtual Mentor. 2004 Dec 1;6(12). pii: virtualmentor.2004.6.12.ccas3-0412. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412. No abstract available.

20.

Parceling component effects of a multifaceted prevention program for disruptive elementary school children.

August GJ, Egan EA, Realmuto GM, Hektner JM.

J Abnorm Child Psychol. 2003 Oct;31(5):515-27.

PMID:
14561059
21.

Ethics training in graduate medical education.

Egan EA.

Am J Bioeth. 2002 Fall;2(4):26-8. No abstract available.

PMID:
12762916
22.

Organizational ethics in residency training: moral conflict with supervising physicians.

Egan EA.

Camb Q Healthc Ethics. 2003 Winter;12(1):119-23. No abstract available.

PMID:
12625210
23.

Predictors of treatment response in anxious-depressed adolescents with school refusal.

Layne AE, Bernstein GA, Egan EA, Kushner MG.

J Am Acad Child Adolesc Psychiatry. 2003 Mar;42(3):319-26.

PMID:
12595785
24.

The early risers longitudinal prevention trial: examination of 3-year outcomes in aggressive children with intent-to-treat and as-intended analyses.

August GJ, Hektner JM, Egan EA, Realmuto GM, Bloomquist ML.

Psychol Addict Behav. 2002 Dec;16(4S):S27-39.

PMID:
12502275
25.

Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder.

Fatemi SH, Stary JM, Egan EA.

Cell Mol Neurobiol. 2002 Apr;22(2):139-52.

PMID:
12363196
26.

Patents: the public interest versus the private privilege.

Parsi KP, Egan EA.

Am J Bioeth. 2002 Summer;2(3):45-6. No abstract available.

PMID:
12230857
27.

Component-specific surface and physiological activity in bovine-derived lung surfactants.

Notter RH, Wang Z, Egan EA, Holm BA.

Chem Phys Lipids. 2002 Jan;114(1):21-34.

PMID:
11841823
28.

High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome.

Kattwinkel J, Bloom BT, Delmore P, Glick C, Brown D, Lopez S, Willett L, Egan EA, Conaway M, Patrie J.

Pediatrics. 2000 Aug;106(2 Pt 1):282-8.

PMID:
10920152
29.

Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network.

Willson DF, Zaritsky A, Bauman LA, Dockery K, James RL, Conrad D, Craft H, Novotny WE, Egan EA, Dalton H.

Crit Care Med. 1999 Jan;27(1):188-95.

PMID:
9934915
30.

Increased survival in low birth weight neonates given prophylactic surfactant.

Brown DR, Bloom BT, Cohen M, Myers MM, Egan EA, Kattwinkel J, Delmore P, Hall RT, Malloy MH, Holzman IR, Carlo WA, Pramanik AK, McCaffree MA, Weatherstone KB, Willett LD, Topper WH.

J Perinatol. 1998 Nov-Dec;18(6 Pt 1):431-5.

PMID:
9848755
31.

Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases.

Egan EA, Solomon MJ.

Mol Cell Biol. 1998 Jul;18(7):3659-67.

32.

A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.

Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR Jr, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P.

Pediatrics. 1997 Jul;100(1):39-50.

PMID:
9200358
33.

Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.

Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, Malloy MH, Brown DR, Holzman IR, Coghill CH, Carlo WA, Pramanik AK, McCaffree MA, Toubas PL, Laudert S, Gratny LL, Weatherstone KB, Seguin JH, Willett LD, Gutcher GR, Mueller DH, Topper WH.

Pediatrics. 1997 Jul;100(1):31-8.

PMID:
9200357
34.

Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.

Holm BA, Wang Z, Egan EA, Notter RH.

Pediatr Res. 1996 May;39(5):805-11.

PMID:
8726232
35.

Surfactant decreases pulmonary vascular resistance and increases pulmonary blood flow in the fetal lamb model of congenital diaphragmatic hernia.

O'Toole SJ, Karamanoukian HL, Morin FC 3rd, Holm BA, Egan EA, Azizkhan RG, Glick PL.

J Pediatr Surg. 1996 Apr;31(4):507-11.

PMID:
8801301
36.

A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.

Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ, Horgan MJ, Buckwald S, Belcastro MR, Donohue PK, Carrion V, Maniscalco WW, Balsan MJ, Torres BA, Miller RR, Jansen RD, Graeber JE, Laskay KM, Matteson EJ, Egan EA, Brody AS, Martin DJ, Riddlesberger MM, Montgomery P.

J Pediatr. 1996 Mar;128(3):396-406.

PMID:
8774514
37.

Pre- versus post-ventilatory surfactant treatment in surfactant-deficient preterm lambs.

Cummings JJ, Holm BA, Nickerson PA, Ferguson WH, Egan EA.

Reprod Fertil Dev. 1995;7(5):1333-8.

PMID:
8848608
38.

Impact of lung surfactant therapy on chronic lung diseases in premature infants.

Hudak BB, Egan EA.

Clin Perinatol. 1992 Sep;19(3):591-602. Review.

PMID:
1526073
39.

Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH.

Glick PL, Leach CL, Besner GE, Egan EA, Morin FC, Malanowska-Kantoch A, Robinson LK, Brody A, Lele AS, McDonnell M, et al.

J Pediatr Surg. 1992 Jul;27(7):866-9.

PMID:
1640336
40.

Pulmonary hemodynamics in fetal lambs during development at normal and increased oxygen tension.

Morin FC 3rd, Egan EA.

J Appl Physiol (1985). 1992 Jul;73(1):213-8.

PMID:
1506372
41.

Synthetic surfactants in infants with respiratory distress syndrome.

Egan EA.

N Engl J Med. 1992 Jun 18;326(25):1704; author reply 1704-5. No abstract available.

PMID:
1588993
42.

A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.

Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA.

Am Rev Respir Dis. 1992 May;145(5):999-1004.

PMID:
1586078
43.

Prevention of neonatal necrotizing enterocolitis.

Carrion V, Egan EA.

J Pediatr Gastroenterol Nutr. 1990 Oct;11(3):317-23.

PMID:
2246712
44.

Use of surfactant in the delivery room.

Kwong MS, Holm BA, Egan EA.

Clin Perinatol. 1989 Dec;16(4):853-62. Review.

PMID:
2686891
45.

The effect of closing the ductus arteriosus on the pulmonary circulation of the fetal sheep.

Morin FC 3rd, Egan EA.

J Dev Physiol. 1989 May;11(5):283-7.

PMID:
2614033
46.

Indomethacin does not diminish the pulmonary vascular response of the fetus to increased oxygen tension.

Morin FC 3rd, Egan EA, Norfleet WT.

Pediatr Res. 1988 Dec;24(6):696-700.

PMID:
3205624
47.

Prostacyclin does not change during an oxygen induced increase in pulmonary blood flow in the fetal lamb.

Morin FC 3rd, Egan EA, Lundgren CE, Swartz DD.

Prostaglandins Leukot Essent Fatty Acids. 1988 Jun;32(3):139-44.

PMID:
3045838
48.

Development of pulmonary vascular response to oxygen.

Morin FC 3rd, Egan EA, Ferguson W, Lundgren CE.

Am J Physiol. 1988 Mar;254(3 Pt 2):H542-6.

PMID:
3348432
50.

Alveolar liquid absorption and clearance.

Egan EA.

Am Rev Respir Dis. 1986 Aug;134(2):204. No abstract available.

PMID:
3740645

Supplemental Content

Support Center